HEIDI GREGG: Open Payments
NPI 1801165006 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,637 in 125 payments from 21 companies in 2025. Trend: 2023 $876 · 2024 $2,988 · 2025 $2,637
Food & beverage: $2,403Education: $234
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 32 | $659 |
| GlaxoSmithKline, LLC. | 29 | $365 |
| Verona Pharma, Inc. | 10 | $306 |
| GENZYME CORPORATION | 7 | $197 |
| Actelion Pharmaceuticals US, Inc. | 5 | $177 |
| Regeneron Healthcare Solutions, Inc. | 8 | $136 |
| Insmed, Inc. | 4 | $104 |
| Grifols USA, LLC | 5 | $101 |
| Electromed, Inc. | 5 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
Products named: DUPIXENT, Ohtuvayre, NUCALA, TEZSPIRE, BREZTRI, OPSUMIT, Prolastin-C Liquid, SMARTVEST.
Industry payments across PA — which companies pay providers there.
